No augmentation of indoleamine 2,3-dioxygenase (IDO) activity through belatacept treatment in liver transplant recipients

DSpace Repository

No augmentation of indoleamine 2,3-dioxygenase (IDO) activity through belatacept treatment in liver transplant recipients

Author: Bigenzahn, S.; Juergens, B.; Mahr, B.; Pratschke, J.; Koenigsrainer, A.; Becker, T.; Fuchs, D.; Brandacher, G.; Kainz, A.; Muehlbacher, F.; Wekerle, T.
Tübinger Autor(en):
Königsrainer, Alfred
Published in: Clinical and Experimental Immunology (2018), Bd. 192, H. 2, S. 233-241
Verlagsangabe: Wiley
Language: English
Full text: http://dx.doi.org/10.1111/cei.13093
ISSN: 1365-2249
DDC Classifikation: 570 - Life sciences; biology
610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)